Your browser doesn't support javascript.
loading
Why Is Amyloid-ß PET Requested After Performing CSF Biomarkers?
Reimand, Juhan; Groot, Colin; Teunissen, Charlotte E; Windhorst, Albert D; Boellaard, Ronald; Barkhof, Frederik; Nazarenko, Sergei; van der Flier, Wiesje M; van Berckel, Bart N M; Scheltens, Philip; Ossenkoppele, Rik; Bouwman, Femke.
Afiliação
  • Reimand J; Department of Neurology & Alzheimer Center Amsterdam, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands.
  • Groot C; Department of Health Technologies, Tallinn University of Technology, Tallinn, Estonia.
  • Teunissen CE; Radiology Centre, North Estonia Medical Centre, Tallinn, Estonia.
  • Windhorst AD; Department of Neurology & Alzheimer Center Amsterdam, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands.
  • Boellaard R; Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
  • Barkhof F; Department of Radiology & Nuclear Medicine, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
  • Nazarenko S; Department of Radiology & Nuclear Medicine, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
  • van der Flier WM; Department of Radiology & Nuclear Medicine, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
  • van Berckel BNM; Centre for Medical Image Computing, Medical Physics and Biomedical Engineering, UCL, United Kingdom.
  • Scheltens P; Department of Health Technologies, Tallinn University of Technology, Tallinn, Estonia.
  • Ossenkoppele R; Department of Neurology & Alzheimer Center Amsterdam, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands.
  • Bouwman F; Department of Epidemiology & Biostatistics, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands.
J Alzheimers Dis ; 73(2): 559-569, 2020.
Article em En | MEDLINE | ID: mdl-31796674
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores / Peptídeos beta-Amiloides / Tomografia por Emissão de Pósitrons Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Alzheimers Dis Assunto da revista: GERIATRIA / NEUROLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Holanda País de publicação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores / Peptídeos beta-Amiloides / Tomografia por Emissão de Pósitrons Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Alzheimers Dis Assunto da revista: GERIATRIA / NEUROLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Holanda País de publicação: Holanda